The DOI matches its Crossref record.
Peptidomimetic Regulation of Growth Hormone Secretion
Abstract
HORMONES are generally released episodically, yet to our knowledge no attempt has been made to design drugs for treating hormone deficiencies that imitate or amplify the endogenous oscillators governing pulsatile hormone release. For example, although GH is normally secreted in a pulsatile manner with peaks occurring approximately every 3 h, GH deficiency is treated by injecting recombinant GH either once daily or every 3 days. Clearly, this dosing regimen does not result in a physiological GH profile and urges the development of a more natural approach for the treatment of GH deficiency. For convenience to the patient, a pathway was sought that could be activated by a drug given orally once daily. By design, conventional peptides were excluded, because the molecular template had to be readily manipulable for optimization of oral absorption and pharmacokinetics. A receptor that controlled GH release by interaction with an endogenous small molecule was unknown, necessitating a heterodox approach to drug discovery. This reverse pharmacology involved: 1) establishing assays for the functional endpoint, stimulation of episodic GH release; 2) understanding at the cellular level how known peptides controlled GH release so that new specific targets of intervention could be selected; 3) identifying selective GH secretagogues of appropriate structure for optimization of pharmacokinetic properties; 4) characterizing and cloning the receptor for these ligands; and 5) identifying the receptor’s natural ligand. This review provides a summary of points 1–4, focusing on the discovery and properties of new GH secretagogues. These molecules were subsequently shown to be peptide mimetics of the GH-releasing peptides (GHRPs) first identified by the pioneering work of Bowers, Momany, and colleagues (1–3); for a comprehensive review of GHRPs the reader is referred to Refs. 4–9. The natural ligand for the receptor activated by GHRPs and its peptidomimetics remains elusive, but now that the receptor has been cloned and distributed, we anticipate its ligand will soon be discovered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor
Kojima, M., Hosoda, H., Matsuo, H., & Kangawa, K. (2001) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00362-3 · Cited by 516
Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity
Muccioli, G., Tschöp, M., Papotti, M., Deghenghi, R., Heiman, M., & Ghigo, E. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01432-2 · Cited by 385
A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control
Dornonville de la Cour, C., Björkqvist, M., Sandvik, A. K., Bakke, I., Zhao, C.-M., Chen, D., & Håkanson, R. (2001) · Regulatory Peptides · doi:10.1016/s0167-0115(01)00243-9 · Cited by 364
Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature
Pantel, J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25303 · Cited by 358
Cardiac cachexia: A systematic overview
von Haehling, S., Lainscak, M., Springer, J., & Anker, S. D. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.09.009 · Cited by 348
Metadata
- Authors
- Smith, R. G.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 1997-10-01
- Volume
- 18
- Issue
- 5
- Pages
- 621-645
- ISSN
- 0163-769X (ISSN-L)
- OpenAlex
- W4239095299
- Cited by
- 160
- References
- 0
- FWCI
- 7.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Peptidomimetic Regulation of Growth Hormone Secretion. https://app.cochat.ai/papers/10.1210/er.18.5.621
- The paper
- Smith, R. G. (1997). Peptidomimetic Regulation of Growth Hormone Secretion. Endocrine Reviews. https://doi.org/10.1210/er.18.5.621
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.